Literature DB >> 25977164

Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs.

Ana Rosa Remacha1, Laura Barrachina1, Samuel Álvarez-Arguedas1, Beatriz Ranera1, Antonio Romero2, Francisco José Vázquez2, Pilar Zaragoza1, Rosa Yañez3, Inmaculada Martín-Burriel1, Clementina Rodellar4.   

Abstract

The immunomodulatory capacities of mesenchymal stem cells (MSCs) have made them the subject of increased clinical interest for tissue regeneration and repair. We have studied the immunomodulatory capacity of equine MSCs derived from bone marrow (BM-MSCs) and adipose tissue (AT-MSCs) in cocultures with allogeneic peripheral blood mononuclear cells (PBMCs). Different isoforms and concentrations of phytohaemaglutinin (PHA) were tested to determine the best stimulation conditions for PBMC proliferation and a proliferation assay was performed for 7 days to determine the optimal day of stimulation of PBMCs. The effect of the dose and source of MSCs was evaluated in cocultures of 10(5) PBMCs with different ratios of AT- and BM-MSCs (1:1, 1:10, 1:20 and 1:50). Proliferation rates of the PBMCs were evaluated using BrdU ELISA colorimetric assay. PHA stimulated equine PBMCs reached their peak of growth after 3 days of culture. The immunoassay showed a decrease of the PBMCs growth at high ratio cocultures (1:1 and 1:10). Equine BM-MSCs and AT-MSCs demonstrated an ability to suppress the proliferation of stimulated PBMCs. Although MSCs derived from both sources displayed immunosuppressive effects, AT-MSCs were slightly more potent than BM-MSCs. In addition, the expression of 26 genes coding for different molecules implicated in the immune response was analyzed in cocultures of BM-MSCs and PHA stimulated PBMSCs by reverse transcriptase real time quantitative PCR (RT-qPCR). An upregulation in genes associated with the production of interleukins and cytokines such as TNF-α and TGF-β1 was observed except for IFN-γ whose expression significantly decreased. The variations of interleukins and cytokine receptors showed no clear patterns. COX-1 and COX-2 showed similar expression patterns while INOs expression significantly decreased in the two cell types present in the coculture. Cyclin D2 and IDO-1 showed an increased expression and CD90, ITG-β1 and CD44 expression decreased significantly in BM-MSCs cocultured with PHA stimulated PBMCs. On the contrary, CD6 and VCAM1 expression increased in these cells. With regard to the expression of the five genes involved in antigen presentation, an upregulation was observed in both cocultured MSCs and stimulated PBMCs. This study contributes to the knowledge of the immunoregulatory properties of equine MSCs, which are notably important for the treatment of inflammation processes, such as tendinitis and osteoarthritis.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipose tissue; Bone marrow; Horse; Immunomodulation; Mesenchymal stem cells

Mesh:

Substances:

Year:  2015        PMID: 25977164     DOI: 10.1016/j.vetimm.2015.04.004

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  hUC-MSCs: evaluation of acute and long-term routine toxicity testing in mice and rats.

Authors:  Jianwei Xu; Gang Liu; Xianyao Wang; Ya'nan Hu; Hongyang Luo; Lan Ye; Zhanhui Feng; Chen Li; Menglan Kuang; Lijuan Zhang; Yixia Zhou; Xiaolan Qi
Journal:  Cytotechnology       Date:  2022-01-05       Impact factor: 2.058

2.  Equine Mesenchymal Stem Cells Influence the Proliferative Response of Lymphocytes: Effect of Inflammation, Differentiation and MHC-Compatibility.

Authors:  Alina Cequier; Antonio Romero; Francisco J Vázquez; Arantza Vitoria; Elvira Bernad; Sara Fuente; Pilar Zaragoza; Clementina Rodellar; Laura Barrachina
Journal:  Animals (Basel)       Date:  2022-04-11       Impact factor: 3.231

3.  Utility of a Mouse Model of Osteoarthritis to Demonstrate Cartilage Protection by IFNγ-Primed Equine Mesenchymal Stem Cells.

Authors:  Marie Maumus; Gautier Roussignol; Karine Toupet; Geraldine Penarier; Isabelle Bentz; Sandrine Teixeira; Didier Oustric; Mireille Jung; Olivier Lepage; Regis Steinberg; Christian Jorgensen; Danièle Noel
Journal:  Front Immunol       Date:  2016-09-27       Impact factor: 7.561

4.  Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses.

Authors:  Ana Leda F Longhini; Tatiana E Salazar; Cristiano Vieira; Thao Trinh; Yaqian Duan; Louise M Pay; Sergio Li Calzi; Megan Losh; Nancy A Johnston; Huisheng Xie; Minsu Kim; Robert J Hunt; Mervin C Yoder; Domenico Santoro; Taralyn M McCarrel; Maria B Grant
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

5.  Pluripotency and immunomodulatory signatures of canine induced pluripotent stem cell-derived mesenchymal stromal cells are similar to harvested mesenchymal stromal cells.

Authors:  Arash Shahsavari; Prasanna Weeratunga; Dmitry A Ovchinnikov; Deanne J Whitworth
Journal:  Sci Rep       Date:  2021-02-10       Impact factor: 4.379

6.  Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.

Authors:  Jennifer M Cassano; Lauren V Schnabel; Margaret B Goodale; Lisa A Fortier
Journal:  Stem Cell Res Ther       Date:  2018-04-03       Impact factor: 6.832

7.  Homing and Engraftment of Intravenously Administered Equine Cord Blood-Derived Multipotent Mesenchymal Stromal Cells to Surgically Created Cutaneous Wound in Horses: A Pilot Project.

Authors:  Suzanne J K Mund; Eiko Kawamura; Awang Hazmi Awang-Junaidi; John Campbell; Bruce Wobeser; Daniel J MacPhee; Ali Honaramooz; Spencer Barber
Journal:  Cells       Date:  2020-05-08       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.